Key facts
- Healthnix’s last known valuation is $4.6M (Feb 2025).
- It has raised $510K; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include Entrepreneurs Roundtable Accelerator, AgeTech Collaborative from AARP, DigitalHealth.London Accelerator, S20.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Healthnix
- ·The full record, as it builds
Funding rounds
No funding rounds for Healthnix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Healthnix
Provider of personalized osteoarthritis nutrition programs intended to reduce inflammation and arthritis pain. The company offers a science-backed anti-inflammatory diet and lifestyle program created by human experts augmented by artificial intelligence, enabling customers to receive personalized, in-depth health insights, health coach support, and a nutrition plan to reduce inflammation in the body.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 10
- Website
- healthnix.io/
- Ownership
- Privately Held (backing)
Healthnix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Healthnix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Healthnix in its N-PORT filings yet. We sweep new filings monthly.